Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease-Reference-Cited by-同舟云学术

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease

Published:2008-05 Issue:5 Volume:63 Page:621-631
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Kadir Ahmadul,Andreasen Niels,Almkvist Ove,Wall Anders,Forsberg Anton,Engler Henry,Hagman Göran,Lärksäter Marie,Winblad Bengt,Zetterberg Henrik,Blennow Kaj,Långström Bengt,Nordberg Agneta

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.21345/fullpdf

Reference48 articles.

1. Current and emerging pharmacological treatment options for dementia;Ringman;Behav Neurol,2006

2. Phenserine regulates translation of beta-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development;Shaw;Proc Natl Acad Sci U S A,2001

3. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice;Lahiri;J Pharmacol Exp Ther,2007

4. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576;Chauhan;J Neurosci Res,2003

5. Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations;Lombardo;J Neurosci,2003

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Modern Approach to the Treatment of Traumatic Brain Injury;Medicines;2024-04-30

2. Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol;BMC Neurology;2024-04-04

3. Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging usingin vivoimaging: the ERAP phase IIa clinical study protocol;2024-02-20

4. Directed evolution of C-methyltransferase PsmD for enantioselective pyrroloindole derivative production;Catalysis Science & Technology;2024

5. Network Pharmacology for Drug Repositioning in Anti-Alzheimer’s Drug Development;Neuromethods;2023